Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
For patients suffering with chronic neuropathic pain the need for suitable novel therapies is imperative. Over recent years a contributing factor for the lack of development of new analgesics for neuropathic pain has been the mismatch of primary neuropathic pain assessment endpoints in preclinical v...
Main Authors: | Amy S. Fisher, Michael T. Lanigan, Neil Upton, Lisa A. Lione |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.614990/full |
Similar Items
-
Deficits in Burrowing Behaviors Are Associated With Mouse Models of Neuropathic but Not Inflammatory Pain or Migraine
by: Andrew J. Shepherd, et al.
Published: (2018-06-01) -
Comparison of burrowing and stimuli-evoked pain behaviors as end-points in rat models of inflammatory pain and peripheral neuropathic pain
by: Arjun eMuralidharan, et al.
Published: (2016-05-01) -
Translational issues in precision medicine in neuropathic pain
by: Anthony H. Dickenson, et al.
Published: (2020-01-01) -
Central neuropathic pain
by: João Batista Santos Garcia, et al. -
Cancer-Related Neuropathic Pain
by: Helen L. Edwards, et al.
Published: (2019-03-01)